About Precision Neuroscience
Precision Neuroscience is a company based in New York (United States) founded in 2021 by Benjamin Rapoport, Demetrios Papageorgiou, Mark Hettick, and Michael Mager. Precision Neuroscience has raised $182.65 million across 6 funding rounds from investors including Mubadala, Jdpglobal and General Equity Holdings. The company has 22 employees as of December 31, 2022. Precision Neuroscience offers products and services including Layer 7 Cortical Interface and Processing Unit. Precision Neuroscience operates in a competitive market with competitors including Blackrock Neurotech, Nexstim, MindMaze, INBRAIN Neuroelectronics and Synergia Medical, among others.
- Headquarter New York, United States
- Employees 22 as on 31 Dec, 2022
- Founders Benjamin Rapoport, Demetrios Papageorgiou, Mark Hettick, Michael Mager
-
Sectors
HealthcareTechnology
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$182.65 M (USD)
in 6 rounds
-
Latest Funding Round
Not available
-
Investors
Mubadala
& 10 more
-
Employee Count
22
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Precision Neuroscience
Precision Neuroscience offers a comprehensive portfolio of products and services, including Layer 7 Cortical Interface and Processing Unit.
Implantable device records brain signals to control digital devices.
Translates recorded brain signals into actionable data for devices.
Funding Insights of Precision Neuroscience
Precision Neuroscience has successfully raised a total of $182.65M across 6 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Precision Neuroscience
Precision Neuroscience has secured backing from 11 investors, including institutional and venture fund investors. Prominent investors backing the company include Mubadala, Jdpglobal and General Equity Holdings.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multistage investments are directed toward technology, healthcare, and climate sectors.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Precision Neuroscience
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Precision Neuroscience
Investment portfolio details for Precision Neuroscience
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Precision Neuroscience
Detailed financials for Precision Neuroscience
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Precision Neuroscience Comparisons
Peer comparison for Precision Neuroscience
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Precision Neuroscience
Precision Neuroscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Blackrock Neurotech, Nexstim, MindMaze, INBRAIN Neuroelectronics and Synergia Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Medical devices for neurological therapies are developed.
|
|
| Locked | Locked | Locked |
Noninvasive brain stimulation is provided for stroke patient rehabilitation.
|
|
| Locked | Locked | Locked |
Evidence-based digital neurotherapeutics are developed for brain health recovery.
|
|
| Locked | Locked | Locked |
AI-based neuroelectronic devices for brain disorder detection are developed.
|
|
| Locked | Locked | Locked |
Implantable neurostimulators and contactless monitoring systems are developed.
|
Detailed competitors of Precision Neuroscience
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Precision Neuroscience
Complete news archive for Precision Neuroscience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Precision Neuroscience
Precision Neuroscience was founded in 2021.
Precision Neuroscience is headquartered in New York, United States. It is registered at New York, New York, United States.
Michael Mager is the current CEO of Precision Neuroscience. They have also founded this company.
Precision Neuroscience is a funded company, having raised a total of $182.65M across 6 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Precision Neuroscience is 22.
Precision Neuroscience was founded in 2021 in New York, United States, within the neuroscience sector. Brain-computer interface technologies are created by the company for applications in medical treatments and drug development. Operations focus on implants that enable AI-based computing, device integration, and neurological assessments. These tools support evaluations of illnesses and advancements in therapeutic solutions.
Precision Neuroscience's top competitors include Blackrock Neurotech, INBRAIN Neuroelectronics and Nexstim.
Precision Neuroscience offers Layer 7 Cortical Interface and Processing Unit.
Precision Neuroscience has 11 investors. Key investors include Mubadala, Jdpglobal, General Equity Holdings, B Capital, and Duquesne Family Office.